BOC

In this episode of Breast Cancer Insights, Harold Burstein, MD, PhD, speaks with Dana-Farber breast cancer experts Sara Tolaney, MD, MPH; Nancy Lin, MD; Erica Mayer, MD, MPH; and Jennifer Ligibel, MD, about important breast cancer research presented at the 2026 ASCO Annual Meeting. The experts discuss new findings across breast cancer, including advances in treatment, clinical trial results, and r...

In this Breast Cancer Breakthroughs series, Harold Burstein, MD, PhD, speaks with breast cancer experts from Dana-Farber about new research presented at the 2026 ASCO Annual Meeting. Topics include advances in early and metastatic breast cancer, new treatment approaches, clinical trial results, food access and poverty, weight loss and lifestyle, and emerging therapies such as antibody-drug conjuga...

Harold Burstein, MD, PhD, and Ana C. Garrido-Castro, MD, discuss the ASCENT-04, ASCENT-03, TROPION-Breast02, ASCENT-07, and OptiTROP-Breast02 trials researching antibody-drug conjugates (ADCs) for breast cancer.  For more information about Dana-Farber's Breast Oncology Center, visit https://www.dana-farber.org/cancer-care/treatment/breast-oncology Test 1